Biology Reference
In-Depth Information
Jolly D, Chada S, et al. 1992. CTL cross reactivity between HIV strains. AIDS Res Hum Retro-
viruses 8: 1369±1371.
Kajino K, Kajino Y, et al. 1998. Fas- and perforin-independent mechanism of cytotoxic T lym-
phocyte. Immunol Res 17: 89±93.
Kalams SA, Walker BD. 1994. The cytotoxic T-lymphocyte response in HIV-1 infection. Clin Lab
Med 14: 271±299.
Kalams SA, Goulder PJ, et al. 1999. Levels of human immunode®ciency virus type 1-speci®c cyto-
toxic T-lymphocyte e¨ector and memory responses decline after suppression of viremia with
highly active antiretroviral therapy. J Virol 73: 6721±6728.
Kaul R, Plummer FA, et al. 2000. HIV-1-speci®c mucosal CD8
lymphocyte responses in the
cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol 164: 1602±1611.
Klein MR, van Baalen CA, et al. 1995. Kinetics of Gag-speci®c cytotoxic T lymphocyte responses
during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and
long-term asymptomatics. J Exp Med 181: 1365±1372.
Klenerman P, Phillips RE, et al. 1996. Cytotoxic T lymphocytes and viral turnover in HIV type 1
infection. Proc Natl Acad Sci USA 93: 15323±15328.
Knight SC, Askonas BA, et al. 1997. Dendritic cells as targets for cytotoxic T lymphocytes. Adv
Exp Med Biol 417: 389±394.
Koopman G, Wever PC, et al. 1997. Expression of granzyme B by cytotoxic T lymphocytes in the
lymph nodes of HIV-infected patients. AIDS Res Hum Retroviruses 13: 227±233.
Koup RA, Safrit JT, et al. 1994. Temporal association of cellular immune responses with the initial
control of viremia in primary human immunode®ciency virus type 1 syndrome. J Virol 68:
4650±4655.
Kourilsky P, Bousso P, et al. 1998. Immunological issues in vaccine trials: T-cell responses. Dev Biol
Stand 95: 117±124.
Krakauer DC, Nowak M. 1999. T-cell induced pathogenesis in HIV: bystander e¨ects and latent
infection. Proc R Soc Lond B Biol Sci 266: 1069±1075.
Kyburz D, Speiser DE, et al. 1993. Lysis of infected cells in vivo by antiviral cytolytic T cells dem-
onstrated by release of cell internal viral proteins. Eur J Immunol 23: 1540±1545.
Larsson M, Jin X, et al. 1999. A recombinant vaccinia virus based ELISPOT assay detects high
frequencies of Pol-speci®c CD8 T cells in HIV-1-positive individuals. AIDS 13: 767±777.
Lewis DE, Tang DS, et al. 1994. Anergy and apoptosis in CD8
T cells from HIV-infected persons.
J Immunol 153: 412±420.
Lichtenfels R, Biddison WE, et al. 1994. CARE-LASS (calcein-release-assay), an improved
¯uorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods
172: 227±239.
Lynch JA, deSouza M, et al. 1998. Cross-clade cytotoxic T cell response to human immuno-
de®ciency virus type 1 proteins among HLA disparate North Americans and Thais. J Infect Dis
178: 1040±1046.
Matzinger P. 1991. The JAM test. A simple assay for DNA fragmentation and cell death. J Im-
munol Methods 145: 185±192.
McMichael AJ, Ogg G, et al. 2000. Memory CD8
T cells in HIV infection. Philos Trans R Soc
Lond B Biol Sci 355: 363±367.
Mehta-Damani A, Markowicz S, et al. 1994. Generation of antigen-speci®c CD8
CTLs from naive
precursors. J Immunol 153: 996±1003.
Miedema F, Klein MR. 1996. AIDS pathogenesis: a ®nite immune response to blame? [comment].
Science 272: 505±506.
Musey L, Hu Y, et al. 1997a. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected
women. J Exp Med 185: 293±303.
